Viewing Study NCT03452332


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2025-12-25 @ 7:37 PM
Study NCT ID: NCT03452332
Status: COMPLETED
Last Update Posted: 2023-09-13
First Post: 2018-02-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module